Axogen to report Q3 2026 financial results on October 28 with a live webcast and call.

Axogen, Inc., a leader in surgical solutions for peripheral nerve repair, will announce its third quarter 2026 financial results on October 28, 2026. Following the release, the company will host a conference call and webcast for investors to discuss the results. Axogen recently expanded its product portfolio with the acquisition of BioCircuit Technologies and a $208.7 million public stock offering, signaling ongoing growth and innovation in nerve repair technology.

Axogen, Inc. shares are currently trading at USD 36.54 on Pluang, showing a 1.02% increase in the last day. The stock has a market cap of $2.12 billion and a typical hold time of 18 days among investors. These figures are as of Oct 14, 2026 18:11 WIB.